Welcome to the tenth edition of Drugs and Pharmacology. Today, we discuss a variety of topics from novel biological approaches to battling memory impairment to the bloody side effects of taking SSRIs and NSAIDs together. Remember, we review the latest blogs related to drugs — medicinal, recreational,... Read more →

One of the main functions of pharmaceutical representatives is to provide free samples to doctors’ offices instead of what has historically been their vocation: implementing authentic and ethical persuasion via presentations. Yet presently, samples are a priority and delivering them is the primary... Read more →

A recent issue of the journal Neurology published two separate case-controlled studies that showed a decreased risk for Parkinson’s disease associated with both cholesterol-lowering medication and blood pressure-lowering medication. A common class of cholesterol-lowering medications, HMG-CoA reductase... Read more →

Our series on Medicine and Law is starting to wind down. We’ve covered lots of topics including contract and consent, malpractice, causation, informed consent, and abandonment. Now we will talk about third-party liability. Third party liability means exactly what it says — that a different... Read more →

With the Olympics in full swing, I cannot help but marvel at the strength, power, skill, and commitment of the athletes. Many of these men and women seemed destined for sports from an early age, while others trained hard to beat the odds and become world-class athletes. Most of us watching the games... Read more →

The problems of childhood obesity are not exclusive to American soil. Both the U.S. and many European countries face this crisis. Various solutions have been proposed and executed. Everything from promoting exercise to teaching children about the origin of their food to banning candy or sweets on school... Read more →

Most humans do not have the power to predict the future, but we can see it. At least we can see one-tenth of a second of it. The May-June issue of the journal Cognitive Science published a review by Mark Changizi of Rensselaer Polytechnic Institute, claiming that the human visual system has evolved to... Read more →

There is a culture to medicine that I alluded to in my previous post about how everyone in the hospital is your boss. In essence, medicine is a profession like no other where “scutwork,” “malignancy” and “bad-mouthing” colleagues is standard practice. In the academic... Read more →

When Medicare was signed in to law by President Johnson in 1965, it was intended to serve as a central funding resource for persons over 65 years, and people with disabilities. Over the years millions of people have benefited from the financial medical pool that Medicare is — providing healthcare... Read more →

I’m going to make a departure from the usual Brain Blogger content today to discuss an event that has arisen in my personal life which I wanted to share. When I was in college, there was a student on campus who had leukemia, and the campus held a drive asking students to donate some blood to be... Read more →

Welcome to the thirty-eight edition of Brain Blogging. In this round, we cover a series on electroconvulsive therapy (ECT), how the brain continuously repairs itself, and a recently approved anti-psychotic drug Invega. Remember, we review the latest blogs related to the brain and mind that go beyond... Read more →